158
Views
7
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Systemic vasoconstriction modulates the responses of pulmonary vasculature and airway to vasoconstrictors in anesthetized rats

, , , &
Pages 324-334 | Received 21 Feb 2015, Accepted 18 Mar 2015, Published online: 07 Jul 2015

REFERENCES

  • Nonas SA, Finigan JH, Gao L, Garcia JG. Functional genomic insights into acute lung injury: role of ventilators and mechanical stress. Proc Am Thorac Soc. 2005;2:188–194.
  • Parker JC, Townsley MI. Evaluation of lung injury in rats and mice. Am J Physiol Lung Cell Mol Physiol. 2004;286:L231–L246.
  • Ryan JJ, Marsboom G,, Archer SL. Rodent models of group 1 pulmonary hypertension. Handb Exp Pharmacol. 2013;218:105–149.
  • Sakao S, Tatsumi K. The effects of antiangiogenic compound SU5416 in a rat model of pulmonary arterial hypertension. Respiration. 2011;81:253–261.
  • Santoian EC, Angerio AD, Schneidkraut MJ, Ramwell PW, Kot PA. Role of calcium in U 46619 and PGF2 alpha pulmonary vasoconstriction in rat lungs. Am J Physiol. 1989;257:H2001–H2005.
  • Raffestin B, Adnot S, Eddahibi S, Macquin-Mavier I, Braquet P, Chabrier PE. Pulmonary vascular response to endothelin in rats. J Appl Physiol. 1991;70:567–574.
  • Rodman DM, Stelzner TJ, Zamora MR, Bonvallet ST, Oka M, Sato K, O'Brien RF, McMurtry IF. Endothelin-1 increases the pulmonary microvascular pressure and causes pulmonary edema in salt solution but not blood-perfused rat lungs. J Cardiovasc Pharmacol. 1992;20:658–663.
  • Nossaman BD, Feng CJ, Wang J, Kadowitz PJ. Analysis of angiotensins I, II, and III in pulmonary vascular bed of the rat. Am J Physiol. 1994;266:L389–L396.
  • Hussain MB, Marshall I. Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery. Br J Pharmacol. 1997;122:849–858.
  • Yildiz G, Demiryürek AT, Gümüşel B, Lippton H. Ischemic preconditioning modulates ischemia-reperfusion injury in the rat lung: role of adenosine receptors. Eur J Pharmacol. 2007;556:144–150.
  • Yamaguchi T, Rodman D, O'Brien R, McMurtry I. Modulation of pulmonary artery contraction by endothelium-derived relaxing factor. Eur J Pharmacol. 1989;161:259– 262.
  • Zhang W, Shibamoto T, Kuda Y, Ohmukai C, Kurata Y. Pulmonary vasoconstrictive and bronchoconstrictive responses to anaphylaxis are weakened via β2-adrenoceptor activation by endogenous epinephrine in anesthetized rats. Anesthesiology. 2011;114:614–623.
  • Rodman DM, Yamaguchi T, O'Brien RF, McMurtry IF. Hypoxic contraction of isolated rat pulmonary artery. J Pharmacol Exp Ther. 1989;248:952–959.
  • Hermo-Weiler CI, Koizumi T, Parker R, Newman JH. Pulmonary vasoconstriction induced by mitral valve obstruction in sheep. J Appl Physiol. 1998;85:1655–1660.
  • Roos A, Thomas LJ, Nagel EL, Prominas DC. Pulmonary vascular resistance as determined by lung inflation and vascular pressures. J Appl Physiol. 1961;16:77–84.
  • Takeshita H, Nishikibe M, Yano M, Ikemoto F. Coronary vascular response to endothelin in isolated perfused hearts of spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 1991;18:661–669.
  • Lee SL, Levitsky S, Feinberg H. Effects of exogenous vasoconstrictors on coronary vascular resistance and prostacyclin production of the quiescent heart: the inhibitory effect of aspirin. J Pharmacol Exp Ther. 1989;248:44–49.
  • Lee SL, Levitsky S, Feinberg H. Endogenous vasoconstrictor prostanoids: role in serotonin and vasopressin-induced coronary vasoconstriction. J Pharmacol Exp Ther. 1991;258:292– 298.
  • Su N, Narayanan N. Age related alteration in cholinergic but not alpha adrenergic response of rat coronary vasculature. Cardiovasc Res. 1993;27:284–290.
  • Homma S, Miyauchi T, Sugishita Y, Goto K, Sato M, Ohshima N. Vasoconstrictor effects of endothelin-1 on myocardium microcirculation studied by the Langendorff perfusion method: differential sensitivities among microvessels. Microvasc Res. 1992;43:205–217.
  • Schmidt DT, Rühlmann E, Waldeck B, Branscheid D, Luts A, Sundler F, Rabe K. The effect of the vasoactive intestinal polypeptide agonist Ro25–1553 on induced tone in isolated human airways and pulmonary artery. Naunyn Schmiedebergs Arch Pharmacol. 2001;364: 314–320.
  • Evora PR, Pearson PJ, Schaff HV. Arginine vasopressin induces endothelium- dependent vasodilatation of the pulmonary artery. V1-receptor mediated production of nitric oxide. Chest. 1993;103:1241–1245.
  • Sai Y, Okamura T, Amakata Y, Toda N. Comparison of responses of canine pulmonary artery and vein to ANG II, bradykinin and vasopressin. Eur J Pharmacol. 1995;282:235–241.
  • Rieg AD, Rossaint R, Uhlig S, Martin C. Cardiovascular agents affect the tone of pulmonary arteries and veins in precision-cut lung slices. PLoS One 2011;6:e29698.
  • Garcia-Villalon AL, Garcia JL, Fernandez N, Monge L, Gómez B, Diéguez G. Regional differences in the arterial response to vasopressin: role of endothelial nitric oxide. Br J Pharmacol. 1996;118:1848–1854.
  • Walker BR, Haynes J Jr, Wang HL, Voelkel NF. Vasopressin-induced pulmonary vasodilation in rats. Am J Physiol. 1989;257:H415–H422.
  • Enomoto M, Pan J, Shifrin Y, Belik J. Age dependency of vasopressin pulmonary vasodilatory effect in rats. Pediatr Res. 2014;75:315–321.
  • Eichinger MR, Walker BR. Enhanced pulmonary arterial dilation to arginine vasopressin in chronically hypoxic rats. Am J Physiol Heart Circ Physiol. 1994;267: H2413–H2419.
  • Eichinger MR, Walker BR. Segmental heterogeneity of NO-mediated pulmonary vasodilation in rats. Am J Physiol Heart Circ Physiol. 1994;267:H494–H499.
  • Jin HK, Yang RH, Chen YF, Thornton RM, Jackson RM, Oparil S. Hemodynamic effects of arginine vasopressin in rats adapted to chronic hypoxia. J Appl Physiol. 1989;66:151–160.
  • Wagner EM, Mitzner W. Effects of bronchial vascular engorgement on airway dimensions. J Appl Physiol. 1996;81:293–301.
  • Koshimizu TA, Nasa Y, Tanoue A, Oikawa R, Kawahara Y, Kiyono Y, Adachi T, Tanaka T, Kuwaki T, Mori T, Takeo S, Okamura H, Tsujimoto G. V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity. Proc Natl Acad Sci U. S. A. 2006;103:7807–7812.
  • Erwald R. Vasopressin tachyphylaxis. A study in conscious man. Acta Chirurgica Scandinavia. 1976;142:30–35.
  • Affolter JT, McKee SP, Helmy A, Jones CR, Newby DE, Webb DJ. Intra-arterial vasopressin in the human forearm: pharmacodynamics and the role of nitric oxide. Clin Pharmacol Ther. 2003;74:9–16.
  • Hamel C, Millette A, Lamontagne D. Role of nitric oxide and protein kinase C in the tachyphylaxis to vasopressin in aortic rings. Life Sci. 2005;77:1069–1081.
  • Millette E, Lamontagne D. Endothelium-dependent and NO-mediated desensitization to vasopressin in rat aorta. Br J Pharmacol. 1996;119:899–904.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.